Respondents see the glucagon-like peptide 1 (GLP-1) drugs as a major advance. They also have concerns about whether insurers ...

Two-thirds (66%) of the respondents to the MHE survey said they expect Prescription Drug User Fee Act (PDUFA) dates to be ...

Bayer’s Jivi is a factor VIII replacement therapy that has been engineered with a compound that allows for less frequent dosing. It is now indicated for patients 7 years of age and older.

The FDA has granted Mesoblast’s stem cell therapy, Ryoncil (remestemcel-L), seven years of orphan drug exclusivity for the ...

Eric Tichy, Pharm.D., M.B.A., vice chair of pharmacy formulary at the Mayo Clinic Health System, explains potential ...

Men and people ages 45 and older face additional risk of serious kidney conditions six to 12 months after their viral illness ...

A personalized gene editing therapy was successfully used to treat an infant with CPS1 deficiency, a disease that causes ...

Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the ...

Recently reported results from an open-label extension trial show positive safety and efficacy results after 52 weeks of use ...

Alli Oakes, executive director of research at Trilliant Health, shared that upcoding is a “prime example” of healthcare waste ...

FDA-approved as the first and only approved first line treatment for advanced squamous cell carcinoma of the anal canal.

There are several ways to address HIV in homeless populations, with the most promising being the low barrier care model, ...